AI and Its Involvement in the Future of Neoantigen Discovery The overabundance of data, constantly developing data acquisition technologies, and the rise of applied AI are significantly accelerating cancer neoantigen immunotherapy research Aleksandar Mihajlovic at APIS Assay Technologies (November 2020)
|